Meissner Filtration Products announced their new manufacturing facility in Co. Mayo is operational. The new facility features a state of the art 930 m² (10,000 ft²) ISO class 7 cleanroom dedicated to the manufacture of Single-Use Systems.
Validation of the facility was completed in mid-April and the facility is currently manufacturing products for their biopharmaceutical and pharmaceutical client base.
“While we had envisaged marking this day with a ribbon cutting ceremony to recognize the efforts of all those involved in bringing this new facility online, this is obviously not possible given Covid-19,” Nigel Cannon, Managing Director said. “This symbolic day will come, but what is of immediate importance, perhaps now more than ever given the current health crisis, is that Meissner has an additional operational manufacturing facility capable of supplying our clients with products critical to the manufacture of life saving medicines including those directly related to Covid-19.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!
Meissner’s new manufacturing facility is over 3900 m² (42,000 ft²), and future expansion plans call for a size increase over the coming years. Initial ground work for this development is set to begin later this year. Meissner anticipated future expansions at the time of purchasing the new Advanced Technology Building from the IDA, by also purchasing the adjacent land.
“While the site is currently fully operational and otherwise ready for customer visits, as a critical supplier to the pharmaceutical industry, it is of primary importance that all of our sites remain operational, and thus, Meissner Ltd. in Castlebar is not currently allowing outside visitors,” Laura Meissner, Executive Director of Quality at Meissner said. “While site visits are not yet possible, we have been actively working with our clients to allow them to remotely review the facility operations and validation thereof prior to a physical visit. Contemporary technology has allowed us to still move forward in spite of the current restrictions.”